News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Day In Review: AstraZeneca PLC (AZN) Enters Two Partnerships


1/31/2007 5:00:15 PM

January 31, 2007 -- AstraZeneca signed two drug development deals, one with Argenta Discovery for chronic obstructive pulmonary disease, and the other with Palatin for obesity; Curis and Genentech began a Phase I test of a Hedgehog antagonist for cancer; Pharmion said the FDA accepted its IND for an oral formulation of azacitidine; Avanir received an approvable letter for an orally disintegrating form of FazaClo, or clozapine; and Sepracor handily beat estimates for Q4 but warned revenues would slip in the first half of 2007. The Centient Biotech 200™ rose 8 points to 4042, an increase of .20%. More details...


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES